The Medicines and Healthcare products Regulatory Agency (MHRA) – the UK’s drug regulator – added an extremely rare nerve-damaging disorder to its list of possible side effects for the AstraZeneca Covid vaccine.
According to the MHRA, Guillain-Barré syndrome (GBS) is a very rare side effect of the AstraZeneca Covid vaccine, the regulatory body announced on Thursday.
Guillain-Barré syndrome is a very rare and serious condition that affects the nerves. It mainly affects the feet, hands and limbs, causing problems such as numbness, weakness and pain.
According to the NHS, it can be treated and most people will eventually make a full recovery, although it can occasionally be life-threatening and some people are left with long-term problems.
READ MORE: Pfizer vaccine: The one side effect more common after booster and it may last for 8 days